Cardiol Therapeutics Inc
F:CT9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cardiol Therapeutics Inc
F:CT9
|
CA |
|
M
|
Metacon AB (publ)
F:M16
|
SE |
|
Greenvolt Energias Renovaveis SA
F:000
|
PT |
|
H
|
Home Depot Inc
XMUN:HDI
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
O
|
Oracle Corp
F:ORC
|
US |
|
I
|
Indika Energy Tbk PT
XMUN:I41
|
ID |
|
C
|
Carrier Global Corp
F:4PN
|
US |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
|
D
|
Dror Ortho-Design Inc
OTC:DROR
|
US |
|
T
|
Texas Mineral Resources Corp
OTC:TMRC
|
US |
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
|
P
|
Persimmon PLC
XMUN:OHP
|
UK |
|
W
|
Wesco International Inc
XMUN:WP7
|
US |
|
Big Medya Teknoloji AS
IST:BIGTK.E
|
TR |
Shareholder Yield
Current shareholder yield for 
CT9 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CT9 Price
Cardiol Therapeutics Inc
| Average Annual Return | -1.18% |
| Standard Deviation of Annual Returns | 70.89% |
| Max Drawdown | -90% |
| Market Capitalization | 345.3m EUR |
| Shares Outstanding | 69 391 504 |
| Percentage of Shares Shorted |
N/A
|
